首页> Journal of clinical microbiology> Molecular Characterization of Mycoplasma pneumoniae Isolates in the United States from 2012 to 2018.

Molecular Characterization of Mycoplasma pneumoniae Isolates in the United States from 2012 to 2018.

导出 OA

翻译打印收藏纠错

第一作者： L,Xiao

第一单位： Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA lixiao@uabmc.edu.

作者： L,Xiao ^[1] ; A E,Ratliff ^[2] ; D M,Crabb ^[2] ; E,Mixon ^[3] ; X,Qin ^[4] ; R,Selvarangan ^[5] ; Y-W,Tang ^[6] ; X,Zheng ^[7] ; J,Dien Bard ^[8] ; T,Hong ^[9] ; M,Prichard ^[3] ; E,Brooks ^[10] ; S,Dallas ^[11] ; L B,Duffy ^[2] ; K B,Fowler ^[3] ; T P,Atkinson ^[3] ; K B,Waites ^[2]

作者单位： Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA lixiao@uabmc.edu. ^[1] Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA. ^[2] Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA. ^[3] Department of Laboratory Medicine and Pathology, Seattle Children's Hospital, Seattle, Washington, USA. ^[4] Children's Mercy Hospital, Kansas City, Missouri, USA. ^[5] Memorial Sloan Kettering Cancer Center, Weill Medical College of Cornell University, New York, New York, USA. ^[6] Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA. ^[7] Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. ^[8] Department of Pathology, Hackensack University Medical Center, Hackensack, New Jersey, USA. ^[9] Departments of Pediatrics, University of Texas Health Science Center, San Antonio, Texas, USA. ^[10] Departments of Pathology, University of Texas Health Science Center, San Antonio, Texas, USA. ^[11]

关键词 MLVA Mycoplasma pneumoniae P1 genotype macrolide resistance variant